Health hazard evaluation report HETA 80-008-1546, BASF Wyandotte Corporation, Rensselaer, New York
A health hazard evaluation at BASF Wyandotte Corporation (SIC-2810, SIC-2820, SIC-2880, SIC-2870), Rensselaer, New York was conducted. The evaluation was requested by a union representative because of adverse pregnancy outcomes among workers involved in the manufacture of 3,5-dinitro-N-4N-4-dipropylsulfanilamide (19044883) (oryzalin). All persons employed from January 1, 1972 through December 31, 1980 were identified from company records. Birth, fetal, and death records were obtained from the State of New York. The authors conclude that workers who were involved in manufacturing oryzalin sired offspring having an unusual cluster of birth defects, especially those of the heart. Whether these were the result of occupational exposure cannot be decisively determined. Implementing proper engineering and work practice controls is recommended.
- Research Organization:
- National Inst. for Occupational Safety and Health, Cincinnati, OH (USA)
- OSTI ID:
- 6300025
- Report Number(s):
- PB-86-105343/XAB; HETA-80-008-1546
- Country of Publication:
- United States
- Language:
- English
Similar Records
Wyandotte Integrated Renewable Energy Strategy (WIRES 2) (Final Technical Report)
Health-hazard evaluation report HETA 80-035-1635, Bofors-Nobel/Lakeway Corporation, Muskegon, Michigan
Related Subjects
99 GENERAL AND MISCELLANEOUS//MATHEMATICS, COMPUTING, AND INFORMATION SCIENCE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
CHEMICAL INDUSTRY
INDUSTRIAL PLANTS
INDUSTRIAL MEDICINE
INDOOR AIR POLLUTION
OCCUPATIONAL SAFETY
PESTICIDES
HAZARDOUS MATERIALS
INSPECTION
TOXICITY
VENTILATION
AIR POLLUTION
INDUSTRY
MATERIALS
MEDICINE
POLLUTION
SAFETY
500200* - Environment
Atmospheric- Chemicals Monitoring & Transport- (-1989)
552000 - Public Health
560306 - Chemicals Metabolism & Toxicology- Man- (-1987)